Skip to main content
Fig. 1 | Parasites & Vectors

Fig. 1

From: Bioassay and molecular monitoring of insecticide resistance status in Aedes albopictus populations from Greece, to support evidence-based vector control

Fig. 1

Aedes albopictus phenotypic and molecular analysis of insecticide resistance status, Greece. Sampling regions: ROD, Rodopi; THES, Thessaloniki; KEF, Kefalonia; PAT, Patras; ATT, Attica; CHS, Chios; KAL, Kalamata; ARG, Argolida; CHA, Chania; RET, Rethymno; HER, Heraklion. Molecular analysis includes the monitoring of: (i) mutations in the VGSC gene (substitutions in 3 loci: V1016G, I1532T and F1534C); (ii) mutations in the CHS-1 gene (substitution I1043L/M/F); and (iii) the presence of multiple CCEae3a and CCEae6a gene copies. Phenotypic analysis in a subgroup of populations includes: (i) CDC bottle bioassays in adult mosquitoes against deltamethrin (dlt) and malathion (mal) and (ii) WHO larval bioassays against Bti and diflubenzuron (dfb)

Back to article page